342 related articles for article (PubMed ID: 24345269)
1. The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia.
Rajagopal L; Massey BW; Huang M; Oyamada Y; Meltzer HY
Curr Pharm Des; 2014; 20(31):5104-14. PubMed ID: 24345269
[TBL] [Abstract][Full Text] [Related]
2. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
Meltzer HY; Rajagopal L; Huang M; Oyamada Y; Kwon S; Horiguchi M
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2181-94. PubMed ID: 24099265
[TBL] [Abstract][Full Text] [Related]
3. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
[TBL] [Abstract][Full Text] [Related]
4. Atypical but not typical antipsychotic drugs ameliorate phencyclidine-induced emotional memory impairments in mice.
Adem A; Madjid N; Stiedl O; Bonito-Oliva A; Konradsson-Geuken Å; Holst S; Fisone G; Ögren SO
Eur Neuropsychopharmacol; 2019 May; 29(5):616-628. PubMed ID: 30910381
[TBL] [Abstract][Full Text] [Related]
5. The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.
Meltzer HY; Horiguchi M; Massey BW
Psychopharmacology (Berl); 2011 Feb; 213(2-3):289-305. PubMed ID: 21212939
[TBL] [Abstract][Full Text] [Related]
6. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
Brown JW; Rueter LE; Zhang M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
[TBL] [Abstract][Full Text] [Related]
7. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
Horiguchi M; Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
Behav Brain Res; 2016 Mar; 301():132-41. PubMed ID: 26342283
[TBL] [Abstract][Full Text] [Related]
8. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY
Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127
[TBL] [Abstract][Full Text] [Related]
9. Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.
Horiguchi M; Hannaway KE; Adelekun AE; Jayathilake K; Meltzer HY
Neuropsychopharmacology; 2012 Sep; 37(10):2175-83. PubMed ID: 22739469
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update.
Cadinu D; Grayson B; Podda G; Harte MK; Doostdar N; Neill JC
Neuropharmacology; 2018 Nov; 142():41-62. PubMed ID: 29196183
[TBL] [Abstract][Full Text] [Related]
11. The role of serotonin receptors in the action of atypical antipsychotic drugs.
Meltzer HY; Massey BW
Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
[TBL] [Abstract][Full Text] [Related]
12. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
Neill JC; Barnes S; Cook S; Grayson B; Idris NF; McLean SL; Snigdha S; Rajagopal L; Harte MK
Pharmacol Ther; 2010 Dec; 128(3):419-32. PubMed ID: 20705091
[TBL] [Abstract][Full Text] [Related]
13. Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia.
Karamihalev S; Prickaerts J; van Goethem NP
Behav Brain Res; 2014 Oct; 272():248-51. PubMed ID: 25036424
[TBL] [Abstract][Full Text] [Related]
14. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.
Neill JC; Grayson B; Kiss B; Gyertyán I; Ferguson P; Adham N
Eur Neuropsychopharmacol; 2016 Jan; 26(1):3-14. PubMed ID: 26655189
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D
Miyauchi M; Neugebauer NM; Meltzer HY
J Psychopharmacol; 2017 Apr; 31(4):442-452. PubMed ID: 28347261
[TBL] [Abstract][Full Text] [Related]
16. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
Pichat P; Bergis OE; Terranova JP; Urani A; Duarte C; Santucci V; Gueudet C; Voltz C; Steinberg R; Stemmelin J; Oury-Donat F; Avenet P; Griebel G; Scatton B
Neuropsychopharmacology; 2007 Jan; 32(1):17-34. PubMed ID: 16936709
[TBL] [Abstract][Full Text] [Related]
17. Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats.
Horiguchi M; Huang M; Meltzer HY
Psychopharmacology (Berl); 2011 Sep; 217(1):13-24. PubMed ID: 21432027
[TBL] [Abstract][Full Text] [Related]
18. Clozapine and glycinamide prevent MK-801-induced deficits in the novel object recognition (NOR) test in the domestic rabbit (Oryctolagus cuniculus).
Hoffman KL; Basurto E
Behav Brain Res; 2014 Sep; 271():203-11. PubMed ID: 24933188
[TBL] [Abstract][Full Text] [Related]
19. The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats.
Horiguchi M; Huang M; Meltzer HY
J Pharmacol Exp Ther; 2011 Aug; 338(2):605-14. PubMed ID: 21558435
[TBL] [Abstract][Full Text] [Related]
20. Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction.
Rajagopal L; Soni D; Meltzer HY
Behav Brain Res; 2018 Sep; 350():31-43. PubMed ID: 29763637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
